We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Moderna Pauses Acrimonious Bid for Patent on mRNA Sequence, Says More Time is Needed for Discussions with NIH
Moderna Pauses Acrimonious Bid for Patent on mRNA Sequence, Says More Time is Needed for Discussions with NIH
Amid an ongoing dispute with the National Institutes of Health (NIH) over who exactly invented the mRNA sequence of Moderna’s COVID-19 vaccine, the company is hitting the pause button on pursuing a patent for the sequence.